Risk factors for central-line-associated bloodstream infections: a focus on comorbid conditions

Area of Science:

• Healthcare epidemiology
• Infection prevention and control
• Clinical risk adjustment

Background:

• Current Centers for Disease Control and Prevention (CDC) risk adjustment for central-line-associated bloodstream infections (CLABSI) inadequately accounts for patient complexity.
• Existing methods primarily adjust for intensive care unit (ICU) type, potentially overlooking significant patient-specific risk factors.

Purpose of the Study:

• To investigate the utility of the Charlson Comorbidity Index (CCI) and the Chronic Disease Score (CDS) in identifying risk factors for CLABSI.
• To evaluate if these comorbidity indices offer improved risk adjustment compared to current CDC methods.

Main Methods:

• A cohort study design was employed.
• Two distinct comorbidity classification schemes, the Charlson Comorbidity Index (CCI) and the Chronic Disease Score (CDS), were utilized to assess patient risk.
• Data analysis focused on identifying associations between comorbidities and CLABSI incidence.

Main Results:

• The study identified specific comorbidities as significant risk factors for CLABSI.
• Analysis using CCI and CDS revealed potential for enhanced risk stratification beyond ICU type.
• Findings underscore limitations in current risk adjustment models.

Conclusions:

• Additional research into risk factors for CLABSI is warranted.
• Electronically available comorbid conditions, assessed via indices like CCI and CDS, should be further explored for improved risk adjustment.
• Current risk adjustment methods may require refinement to incorporate comprehensive comorbidity data.